Alcidion Group Limited · ASX:ALC
Alcidion — Investor Presentation (October 2019)
32 slides from Alcidion's investor presentation, Oct 14, 2019
Slide 1: Investor Presentation
For personal use only Investor Presentation Leading the digital transformation of healthcare Kate Quirke, Group Managing Director October 2019 1
Slide 2: Challenges facing healthcare providers
Challenges facing healthcare providers For personal use only Healthcare providers must adopt technology to improve patient outcomes and deliver efficiencies to meet demand Big single solution EMR is not the answer - care team productivity can drop by 20-30% Demographic Industry Rising Cost Trends Ch
Slide 3: Our Solution
For personal use only Our Solution 3
Slide 4: Better lives by transforming healthcare delivery through smart technology
Better lives by transforming healthcare For personal use only delivery through smart technology • Highly differentiated platform providing 30K 215 42 Beds using our Hospitals across the Healthcare UK, Australia, New organisations smart infrastructure for healthcare technology Zealand transforming he
Slide 5: Uniquely placed to transform healthcare delivery
Uniquely placed to transform For personal use only healthcare delivery • Miya Precision is an innovative events driven platform • Adds real value to existing investment in Electronic Medical Records (EMR) • Better decisions engineering the risk out of healthcare, pushed to the point of care • Busine
Slide 6: Our solution: We're taking our customers from this…
Our solution: We’re taking our customers from this… For personal use only 6
Slide 7: … to smart technology at the point of care
For personal use only … to smart technology at the point of care 7
Slide 8: Our solutions are changing the delivery of healthcare
Our solutions are changing the delivery of healthcare For personal use only • Combines AI-based predictive analytics, • Clinicians know every patients’ status in Clinical Decision Support (CDS) and real-time. mobile alerts in one easy-to-use • Doctors can intervene and prevent patient dashboard dete
Slide 9: Benefits/ROI of our solutions
Benefits/ROI of our solutions For personal use only 50% reduction in 44% increase in 15 minutes saved cardiac arrests clinical attendance for every doctor (per patient interaction) 29% reduction in 100% observation 10% decrease in ED length of stay completion rate patient admissions 9
Slide 10: Attractive revenue model
Attractive revenue model For personal use only Product Contracts: • Miya Precision • Upfront fee for implementation and Product • Patientrack integration Contracts • Smartpage • Annual license fee – payable annually or • Reseller products quarterly, upfront (for SaaS) (e.g. Nextgate, OpenEP) • Fees
Slide 11: Our customers
Our customers For personal use only Departments of Health Health agencies (public & private) Other • Federal and State departments • Typically hospitals which may be grouped • There are many agencies connected to • Oversee financing of healthcare, and in some together to form a Local Health District
Slide 12: Financial Performance
For personal use only Financial Performance
Slide 13: Alcidion's growth since listing
Alcidion’s growth since listing For personal use only Two acquisitions delivered a diversified product platform, enhanced IT and sales capability, significantly improving the Company’s financial position 2016 FEB 2018 JULY 2018 JULY 2018 MARCH 2019 JULY 2019 Alcidion completes FY19 delivered first L
Slide 14: FY2019 Financial Highlights
FY19 Revenue FY2019 Financial Highlights Recurring vs Non-Recurring For personal use only ($m) FY19 Revenue ($m) 20 15 9.0 300% 33% $2.0M $39K 10 INCREASE IN INCREASE ON POSITIVE EBITDA LOSS; 5 7.9 STATUTORY FY2018 COMBINED OPERATIONAL EARNINGS 0 REVENUE PROFORMA CASH FLOW APPROACHING REVENUE BREAKE
Slide 15: Q1 FY2020 Update
Q1 FY2020 Update For personal use only • $12.9M revenue already contracted for FY2020 as at Q1; 16% increase vs PCP FY2019 • $2.54M of new contracts sold in Q1, adding $1.24M revenue to be recognised in FY2020, with total sold revenue out to FY25 of $34.0M • Strategically important contract signed w
Slide 16: Our opportunity for growth
For personal use only Our opportunity for growth Commercial in Confidence
Slide 17: Growth Strategy
Growth Strategy For personal use only Scale existing Geographical business expansion Accelerate growth in existing markets Add Further distribution develop Out of channels Hospital Care 17
Slide 18: Australia – ready to expand
Australia – ready to expand For personal use only Current state of play Selection of key customers • EMR penetration in public sector is high: 60-70% of hospitals (beds) covered by part or all EMR • Hospital spending rising by 4.2% per annum, widespread upgrade of legacy systems underway Strategy •
Slide 19: Australia – opportunity and strategy
Australia – opportunity and strategy For personal use only $240M total market opportunity Market potential focused on Miya Precision and Smartpage • $161M over 5 years for Miya and Smartpage + $85M for Patientrack • 34,000 beds private – this is the 62000 market for Patientrack in Australia AUSTRALI
Slide 20: UK - our largest potential market
UK - our largest potential market For personal use only Current state of play Selection of key customers • Early adopter of new technology within Europe, lags behind US with only 35% of hospitals deploying CDSS as of 2014 • NHSX - government leading push to paperless healthcare • Mix of integrated E
Slide 21: UK – opportunity and strategy
UK – opportunity and strategy For personal use only $582M total market opportunity over Market potential five years for Miya, Patientrack and Smartpage • Miya Precision opportunity: $540M over 5 years • Patientrack opportunity: $42M over 5 years 145000 • Assumes 30% of hospitals still to choose a Pa
Slide 22: NZ - strong existing presence provides future potential to upsell
NZ - strong existing presence provides For personal use only future potential to upsell Current state of play Selection of key customers • Best of breed more commonly used over integrated EMR • Patientrack clear market leader for patient observations in South Island District Health Boards and Northe
Slide 23: NZ – opportunity and strategy
NZ – opportunity and strategy For personal use only $42M total market opportunity over five years for Patientrack, Smartpage Strategy and Miya • Offer an alternative to an integrated EMR • Provide the base for an 10000 interoperability platform to support their best of breed approach • Continue Smar
Slide 24: Global Market Opportunity
Global Market Opportunity For personal use only Number of Hospitals by Region (2016) • Similar drivers for adoption exist 800000 • Shift to digitalisation still at an early 700000 stage in many markets 600000 • Currently analysing markets with 500000 earliest potential 400000 • Canada, Singapore, So
Slide 25: Competitive landscape
Competitive landscape For personal use only Clinical Inter- Clinical Electronic Integration Mobile EMR decision operability Patient flow Communicatio Data analytics observations services support platform n Alcidion ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ EPIC ✔ ✔ ✔ ✔ ✔ Cerner ✔ ✔ ✔ ✔ Intersystems ✔ ✔ Allscripts ✔ ✔ ✔ Orion
Slide 26: The opportunity for Alcidion
The opportunity for Alcidion For personal use only • Large market opportunity at the right time– digital patient data is driving demand for better healthcare analytics • A leading-edge technology suite – increasingly looked upon as a strategic solution for improving healthcare delivery • Differentia
Slide 27: Appendix
For personal use only Appendix Commercial in Confidence
Slide 28: Deep experience in healthcare & IT
Deep experience in healthcare & IT For personal use only KATE QUIRKE COLIN MACKINNON JULIA STEVENS ANDY SMALLMAN GROUP MANAGING CFO & COO GENERAL MANAGER, GM, AU NORTHERN REGION DIRECTOR PRODUCT Kate has more than 25 years of Colin has over 35 years’ experience in Julia is a delivery focussed profes
Slide 29: Deep experience in healthcare & IT
Deep experience in healthcare & IT For personal use only MALCOLM PRADHAN EVIE KARAGIANNIS DONALD KENNEDY KAYE HOCKING DIRECTOR & CHIEF GENERAL MANAGER, AU GENERAL MANAGER, UK GM, MARKETING AND MEDICAL OFFICER SOUTHERN REGION SALES SUPPORT With over 20 years of experience in Evie has worked in Health
Slide 30: Company snapshot
Company snapshot For personal use only Capital Structure Major Shareholders Name Shares Held % issued shares Malcolm Pradhan 134.6m 14.9% Ordinary shares on issue 900.7m Ray Blight 95.8m 10.6% Share price (09/10/19) 0.25 Caledonia Nominees Pty Ltd (Donald Market capitalisation $225m 71.7m 8.0% Kenne
Slide 31: Disclaimer
Disclaimer For personal use only This presentation has been prepared by Alcidion Group Limited (‘Alcidion’). The information in this presentation is of a general nature and does not purport to be complete, nor does it contain all the information which would be required in a prospectus prepared in ac
Slide 32: Contacts
Contacts For personal use only Kyahn Williamson Head of Investor Communication WE Buchan Kwilliamson@we-Buchan.com +61 401 018 828 32
Alcidion Group — Investor Presentation (October 2019) on 6ix